 Connection
Mario Enrico Canonico to Coronary Artery Disease
This is a "connection" page, showing publications Mario Enrico Canonico has written about Coronary Artery Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.377 |
|
|
|
-
Morrison JT, Canonico ME, Anand SS, Patel MR, Debus ES, Nehler MR, Hess CN, Hsia J, Capell WH, Muehlhofer E, Haskell LP, Berkowitz SD, Bauersachs RM, Bonaca MP. Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD. Circulation. 2024 May 07; 149(19):1536-1539.
Score: 0.142
-
Sanna GD, Canonico ME, Siciliano R, Guarino S, Montereggi F, Ponti E, Corda G, Talanas G, Parodi G. Impact of glucose-6-phosphate dehydrogenase deficiency on the severity of coronary atherosclerosis in patients with acute coronary syndromes. J Cardiovasc Med (Hagerstown). 2021 Nov 01; 22(11):813-817.
Score: 0.119
-
Santoro C, Capone V, Canonico ME, Gargiulo G, Esposito R, Sanna GD, Parodi G, Esposito G. Single, Dual, and Triple Antithrombotic Therapy in Cancer Patients with Coronary Artery Disease: Searching for Evidence and Personalized Approaches. Semin Thromb Hemost. 2021 Nov; 47(8):950-961.
Score: 0.116
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|